到 2027 年欧洲结直肠癌市场 - 按模式（诊断类型、治疗类型、影像类型）进行区域分析和预测；最终用户（医院、诊断和研究实验室）和国家/地区
No. of Pages: 181 | Report Code: TIPRE00009258 | Category: Life Sciences
No. of Pages: 181 | Report Code: TIPRE00009258 | Category: Life Sciences
欧洲结直肠癌市场预计将从2022年的46.2782亿美元增长到2028年的581996万美元；预计2022年至2028年复合年增长率为2.9%。
结直肠癌市场被认为是频繁的诊断测试和新药上市。许多主要市场参与者都参与制造各种有助于减轻结直肠癌负担的药物和诊断测试。例如，2021年6月，百时美施贵宝宣布欧盟委员会（EC）批准Opdivo联合Yervoy用于治疗微卫星不稳定性高（MSI-H）转移性结直肠癌成年患者。此外，2019年9月，印度制药公司Lupin与德国制药公司勃林格殷格翰合作开发抗癌药物。两家公司合作开发和商业化一种基于 MEK 抑制剂的药物。该分子可能会针对特定的癌细胞并治疗患有胃癌和皮肤癌的患者。 2019 年 6 月，辉瑞公司推出了 ZIRABEV，这是一种 Avastin 的生物仿制药，有助于治疗包括结直肠癌在内的五种癌症。因此，结直肠癌诊断和治疗领域的不断发展和新产品的推出正在推动欧洲结直肠癌市场的增长。
随着新的功能和技术，供应商可以吸引新客户并扩大他们在新兴市场的足迹。这一因素可能会在预测期内推动欧洲结直肠癌市场实现大幅复合年增长率。
< /strong>
欧洲结直肠癌市场分为模式、最终用户和国家。根据模式，欧洲结直肠癌市场分为诊断类型、治疗类型和影像类型。 2022年，诊断类细分市场占据最大的市场份额，预计在预测期内复合年增长率最高。根据最终用户，欧洲结直肠癌市场分为医院和诊断与治疗。研究实验室。 2022年，医院细分市场占有更大的市场份额。根据国家/地区，欧洲结直肠癌市场分为法国、德国、意大利、西班牙、英国和欧洲其他地区。 2022 年，欧洲其他地区占据最大市场份额。
雅培 (Abbott)、安进公司 (Amgen Inc.)、布鲁克公司 (Bruker Corporation)、EDP Biotech Corporation、Epigenomics AG 、F. Hoffmann-La Roche AG、Quest Diagnostics 和 VolitionRx Limited 是欧洲结直肠癌市场的领先公司之一。
Strategic insights for Europe Colorectal Cancer involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 4,627.82 Million |
| Market Size by 2028 | US$ 5,819.96 Million |
| Global CAGR (2022 - 2028) | 2.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 方式
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Colorectal Cancer refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Colorectal Cancer Market is valued at US$ 4,627.82 Million in 2022, it is projected to reach US$ 5,819.96 Million by 2028.
As per our report Europe Colorectal Cancer Market, the market size is valued at US$ 4,627.82 Million in 2022, projecting it to reach US$ 5,819.96 Million by 2028. This translates to a CAGR of approximately 2.9% during the forecast period.
The Europe Colorectal Cancer Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Colorectal Cancer Market report:
The Europe Colorectal Cancer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Colorectal Cancer Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Colorectal Cancer Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Colorectal Cancer Market
